Circ_0061825 Acts as a miR-593-3p Sponge to Promote Breast Cancer Progression by Regulating FGFR3 Expression

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492.30207593
   PubMed Web of Science ®Google Scholar
• Jhan JR, Andrechek ER. Triple-negative breast cancer and the potential for targeted therapy. Pharmacogenomics. 2017;18(17):1595–1609. doi:10.2217/pgs-2017-0117.29095114
   PubMed Web of Science ®Google Scholar
• Collignon J, Lousberg L, Schroeder H, Jerusalem G. Triple-negative breast cancer: treatment challenges and solutions. Breast Cancer (Dove Med Press). 2016;8:93–107. doi:10.2147/bctt.s69488.27284266
   PubMed Web of Science ®Google Scholar
• Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs. Nat Biotechnol. 2014;32(5):453–461. doi:10.1038/nbt.2890.24811520
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Hansen TB, Venø MT, Kjems J. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018;37(5):555–565. doi:10.1038/onc.2017.361.28991235
   PubMed Web of Science ®Google Scholar
• Nair AA, Niu N, Tang X, et al. As and their associations with breast cancer subtypes. Oncotarget. 2016;7(49):80967–80979. doi:10.18632/oncotarget.13134.27829232
   PubMedGoogle Scholar
• Wang H, Xiao Y, Wu L, Ma D. Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-000911/miR-449a pathway in breast carcinogenesis. Int J Oncol. 2018;52(3):743–754. doi:10.3892/ijo.2018.4265.29431182
   PubMed Web of Science ®Google Scholar
• Zhang HD, Jiang LH, Hou JC, et al. Circular RNA hsa_circ_0052112 promotes cell migration and invasion by acting as sponge for miR-125a-5p in breast cancer. Biomed Pharmacother. 2018;107:1342–1353. doi:10.1016/j.biopha.2018.08.030.30257349
   PubMed Web of Science ®Google Scholar
• Liu Y, Lu C, Zhou Y, Zhang Z, Sun L. Circular RNA hsa_circ_0008039 promotes breast cancer cell proliferation and migration by regulating miR-432-5p/E2F3 axis. Biochem Biophys Res Commun. 2018;502(3):358–363. doi:10.1016/j.bbrc.2018.05.166.29807010
   PubMed Web of Science ®Google Scholar
• Pan G, Mao A, Liu J, Lu J, Ding J, Liu W. Circular RNA hsa_circ_0061825 (circ-TFF1) contributes to breast cancer progression through targeting miR-326/TFF1 signalling. Cell Prolif. 2020;53(2):e12720. doi:10.1111/cpr.12720.31961997
   PubMed Web of Science ®Google Scholar
• Dvinge H, Git A, Gräf S, et al. The shaping and functional consequences of the microRNA landscape in breast cancer. Nature. 2013;497(7449):378–382. doi:10.1038/nature12108.23644459
   PubMed Web of Science ®Google Scholar
• Tavazoie SF, Alarcón C, Oskarsson T, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 2008;451(7175):147–152. doi:10.1038/nature06487.18185580
   PubMed Web of Science ®Google Scholar
• Fan H, Shao M, Huang S, et al. MiR-593 mediates curcumin-induced radiosensitization of nasopharyngeal carcinoma cells via MDR1. Oncol Lett. 2016;11(6):3729–3734. doi:10.3892/ol.2016.4438.27313684
   PubMed Web of Science ®Google Scholar
• Wei F, Wang M, Li Z, Wang Y, Zhou Y. miR-593 inhibits proliferation and invasion and promotes apoptosis in non‑small cell lung cancer cells by targeting SLUG‑associated signaling pathways. Mol Med Rep. 2019;20(6):5172–5182. doi:10.3892/mmr.2019.10776.31661137
   PubMed Web of Science ®Google Scholar
• Song L, Xiao Y. Downregulation of hsa_circ_0007534 suppresses breast cancer cell proliferation and invasion by targeting miR-593/MUC19 signal pathway. Biochem Biophys Res Commun. 2018;503(4):2603–2610. doi:10.1016/j.bbrc.2018.08.007.30139516
   PubMed Web of Science ®Google Scholar
• Daly CS, Flemban A, Shafei M, Conway ME, Qualtrough D, Dean SJ. Hypoxia modulates the stem cell population and induces EMT in the MCF-10A breast epithelial cell line. Oncol Rep. 2018;39(2):483–490. doi:10.3892/or.2017.6125.29207201
   PubMed Web of Science ®Google Scholar
• Rivetti Di Val Cervo P, Lena AM, Nicoloso M. p63-microRNA feedback in keratinocyte senescence. Proc Natl Acad Sci U S A. 2012;109(4):1133–1138. doi:10.1073/pnas.1112257109.22228303
   PubMed Web of Science ®Google Scholar
• Cappiello F, Casciaro B, Mangoni ML. A novel in vitro wound healing assay to evaluate cell migration. J Vis Exp. 2018;(133):56825. doi:10.3791/56825.
   PubMed Web of Science ®Google Scholar
• Smid M, Wilting SM, Uhr K, Rodríguez-González FG, de Weerd V. The circular RNome of primary breast cancer. Genome Res. 2019;29(3):356–366. doi:10.1101/gr.238121.11830692147
   PubMed Web of Science ®Google Scholar
• Li Z, Chen Z, Hu G, Jiang Y. Roles of circular RNA in breast cancer: present and future. Am J Transl Res. 2019;11(7):3945–3954.31396311
   PubMed Web of Science ®Google Scholar
• Li F, Zhang L, Li W, et al. Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β-catenin pathway. Oncotarget. 2015;6(8):6001–6013. doi:10.18632/oncotarget.3469.25749389
   PubMed Web of Science ®Google Scholar
• Wang J, Li X, Lu L, He L, Hu H, Xu Z. Circular RNA hsa_circ_0000567 can be used as a promising diagnostic biomarker for human colorectal cancer. J Clin Lab Anal. 2018;32(5):e22379. doi:10.1002/jcla.22379.29333615
   PubMed Web of Science ®Google Scholar
• Du WW, Zhang C, Yang W, Yong T, Awan FM, Yang BB. Identifying and characterizing circRNA-protein interaction. Theranostics. 2017;7(17):4183–4191. doi:10.7150/thno.21299.29158818
   PubMed Web of Science ®Google Scholar
• Verduci L, Strano S, Yarden Y, Blandino G. The circRNA-microRNA code: emerging implications for cancer diagnosis and treatment. Mol Oncol. 2019;13(4):669–680. doi:10.1002/1878-0261.12468.30719845
   PubMed Web of Science ®Google Scholar
• Dudekula DB, Panda AC, Grammatikakis I, De S, Abdelmohsen K, Gorospe M. CircInteractome: a web tool for exploring circular RNAs and their interacting proteins and microRNAs. RNA Biol. 2016;13(1):34–42. doi:10.1080/15476286.2015.1128065.26669964
   PubMed Web of Science ®Google Scholar
• Dong L, Hong H, Chen X, Huang Z, Wu W, Wu F. LINC02163 regulates growth and epithelial-to-mesenchymal transition phenotype via miR-593-3p/FOXK1 axis in gastric cancer cells. Artif Cells Nanomed Biotechnol. 2018;46(sup2):607–615. doi:10.1080/21691401.2018.1464462.
   PubMed Web of Science ®Google Scholar
• Han W, Wang L, Zhang L, Wang Y, Li Y. Circular RNA circ-RAD23B promotes cell growth and invasion by miR-593-3p/CCND2 and miR-653-5p/TIAM1 pathways in non-small cell lung cancer. Biochem Biophys Res Commun. 2019;510(3):462–466. doi:10.1016/j.bbrc.2019.01.131.30722989
   PubMed Web of Science ®Google Scholar
• Bersani C, Haeggblom L, Ursu RG, et al. Overexpression of FGFR3 in HPV-positive tonsillar and base of tongue cancer is correlated to outcome. Anticancer Res. 2018;38(8):4683–4690. doi:10.21873/anticanres.12774.30061236
   PubMed Web of Science ®Google Scholar
• Fromme JE, Schildhaus HU. FGFR3 overexpression is a relevant alteration in colorectal cancer. Pathologe. 2018;39(Suppl 2):189–192. doi:10.1007/s00292-018-0504-0.30267148
   PubMedGoogle Scholar
• Geelvink M, Babmorad A, Maurer A, Stöhr R, Grimm T. Diagnostic and prognostic implications of FGFR3(high)/Ki67(high) papillary bladder cancers. Int J Mol Sci. 2018;19(9):2548. doi:10.3390/ijms19092548.
   PubMed Web of Science ®Google Scholar
• Frattini V, Pagnotta SM, Tala FJJ, et al. A metabolic function of FGFR3-TACC3 gene fusions in cancer. Nature. 2018;553(7687):222–227. doi:10.1038/nature25171.29323298
   PubMed Web of Science ®Google Scholar
• Costa R, Carneiro BA, Taxter T, et al. FGFR3-TACC3 fusion in solid tumors: mini review. Oncotarget. 2016;7(34):55924–55938. doi:10.18632/oncotarget.10482.27409839
   PubMedGoogle Scholar
• Long X, Shi Y, Ye P, Guo J, Zhou Q, Tang Y. MicroRNA- 99a suppresses breast cancer progression by targeting FGFR3. Front Oncol. 2019;9:1473. doi:10.3389/fonc.2019.01473.32038996
   PubMed Web of Science ®Google Scholar